Overview: Calmodulin and Calmodulin-Antagonists
- 1 November 1992
- journal article
- Published by Informa Healthcare in Current Opinion on Therapeutic Patents
- Vol. 2 (11) , 1889-1917
- https://doi.org/10.1517/13543776.2.11.1889
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymesBiochemical and Biophysical Research Communications, 1988
- Cholesterol hydroperoxides inhibit calmodulin and suppress atherogenesis in rabbitsBiochemical and Biophysical Research Communications, 1987
- The interaction of calmodulin with melittinBiochemical and Biophysical Research Communications, 1986
- Interaction of alpha adrenergic antagonists with calmodulinLife Sciences, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulinBiochemical and Biophysical Research Communications, 1982
- Ca-calmodulin mediates the DNA-synthetic response of calcium-deprived liver cells to the tumor promoter TPA*1, *2Experimental Cell Research, 1982
- Interaction of local anesthetics with calmodulinBiochemical and Biophysical Research Communications, 1981
- R 24571: A new powerful inhibitor of red blood cell Ca++-transport ATPase and of calmodulin-regulated functionsBiochemical and Biophysical Research Communications, 1981
- Calmodulin stimulates human platelet phospholipase A2Biochemical and Biophysical Research Communications, 1979